Navigation Links
The In View series hosted by Larry King Announces plans for a series on Autoimmune Diseases
Date:2/8/2013

Boca Raton, FL (PRWEB) February 08, 2013

The producers of the In View TV series, an educational TV series hosted by Larry King, have announced plans to focus on autoimmune diseases and the push to cure them in an upcoming series. These diseases, which have no cure and often have nebulous causes, afflict tens of millions of Americans, affecting their health and quality of life. Diseases that come under this classification include type-I diabetes, multiple sclerosis and rheumatoid arthritis. The In View Larry King show, which runs on cable outlets across the country, will inform TV audiences about some of the many autoimmune diseases, in which the body’s immune system attacks and destroys healthy tissues and cells, as well as efforts to cure these diseases and develop better treatments for them. The Larry King TV show will spotlight researchers as well as companies across the country working to develop cures and treatments.

In November, researchers at the National Institute of Biomedical Imaging and Bioengineering announced a possible breakthrough in the treatment of autoimmune diseases. The institute’s approach involved re-educating the body’s T-cells to not attack healthy tissue. This series of the In View with Larry King show (http://www.inviewseries.com) will look at advances such as this and more, giving rare attention to diseases and patients that often get overlooked. The In View TV series (855-446-8439) will showcase organizations and companies that have made progress in the fight against various autoimmune disorders and diseases.

The Larry King In View show (561-544-7965) offers enlightening episodes and series on many important and timely subjects throughout American culture. It features veteran television personality Larry King, the long-time host of “Larry King Live” on CNN.

Read the full story at http://www.prweb.com/releases/in-view-with-larry-king/autoimmune-diseases/prweb10413646.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Touch Medical Media Splits From Touch Briefings, Launches a Series of Cutting Edge, Free to Access, Educational Resources and Signs an Updated Media Partnership With ECCO, The European CanCer Organisation Representing 60,000 Oncology Professionals
2. DuPont Pioneer Launches Next Generation T Series Soybeans
3. Management Matters Series Starts with “Lab Budgeting 101”
4. QSI Announces RS Series of Deep Cooled CCD Cameras
5. Cieri Media Announces New Science Series 'Bright Ideas' Focusing on Latest Inventions
6. Rudy Mazzocchi Prepares to Release the Second Thriller in The EQUITY Series Trilogy, entitled EQUITY of FEAR
7. The Veterinary Bioscience Institute Announces an Amazing Series of 41 Webinars for 2013
8. BioTechniques Announces the Publication of 'Transfection' – The First Issue of a New, Digital-Only Spotlight Series
9. Avelas Biosciences Closes $7.65 Million Series A, Advances Real-Time Tumor Visualization Technology Toward Development
10. Rhythm Expands Series B Financing to $33 Million; Adds Pfizer Ventures as an Investor
11. Advanced Cell Diagnostics Completes $12 Million Series B Financing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/17/2017)... , Feb. 17, 2017  If only ... tumor had a mutation-conferring resistance to chemotherapy, thousands ... genomics research has focused on finding these mutations ... even from circulating tumor DNA in blood — ... oncology therapeutics. Unfortunately, however, detecting these ...
(Date:2/16/2017)... ... 2017 , ... Avomeen & MichBio will be hosting a BioMixer next week ... Analytical Services (4840 Venture Dr., Ann Arbor, Michigan 48108). BioMixers are a casual, ... interact with peers, make new connections and talk bio biz. , Cost:, ...
(Date:2/16/2017)... , Feb. 16, 2017  ArmaGen, Inc., ... groundbreaking therapies to treat severe neurological disorders, today ... treated with AGT-181, the company,s investigational therapy for ... known as mucopolysaccharidosis type I, or MPS I). ... proof-of-concept (POC) study, presented today at the 13 ...
(Date:2/16/2017)... 16, 2017 Patient Care ... innovative telemedicine application, new and leading edge therapies ... a boom worldwide. The healthcare sector as whole ... services and new therapies for companies such as ... Cellectar Biosciences, Inc. (NASDAQ: CLRB ), ...
Breaking Biology Technology:
(Date:2/7/2017)... , Feb. 7, 2017   MedNet Solutions , ... entire spectrum of clinical research, is pleased to announce ... , its innovative, highly flexible and award winning eClinical ... customers. iMedNet is a proven Software-as-a-Service (SaaS) ... Data Capture (EDC), but also delivers an entire suite ...
(Date:2/3/2017)... Biomedical Research Institute announced that its Board of Trustees has ... Institute,s new President and CEO. Dr. Schlesinger will take the ... currently the Chair of the Department of Microbial Infection and ... at Ohio State University. "We are delighted to ... Texas Biomed," said Dr. James O. Rubin , Board ...
(Date:2/2/2017)... Feb. 1, 2017  Central to its deep ... advances worldwide, The Japan Prize Foundation today announced ... have pushed the envelope in their respective fields ... Three scientists are being recognized with the 2017 ... not only contribute to the advancement of science ...
Breaking Biology News(10 mins):